Unique ID issued by UMIN | UMIN000042876 |
---|---|
Receipt number | R000048938 |
Scientific Title | Clinical study on the interrelationship between liver, heart, and lung in portal hypertension |
Date of disclosure of the study information | 2021/01/04 |
Last modified on | 2020/12/30 12:51:50 |
Clinical study on the interrelationship between liver, heart, and lung in portal hypertension
The interrelationship between liver, heart, and lung in portal hypertension
Clinical study on the interrelationship between liver, heart, and lung in portal hypertension
The interrelationship between liver, heart, and lung in portal hypertension
Japan |
Portal hypertension
Hepato-biliary-pancreatic medicine |
Others
NO
To examine the frequency of cardiac function abnormalities and pulmonary hypertension in patients with portal hypertension, changes in cardiac function and pulmonary hypertension after treatment of complications of portal hypertension, and to clarify the clinical significance of cirrhotic cardiomyopathy and portopulmonary hypertension.
Others
Epidemiological survey
Frequency of cirrhotic cardiomyopathy and portopulmonary hypertension in patients with portal Hypertension and at 3 months and 1 year
a. Examine the relationship between liver reserve values (blood chemistry, Child-Pugh score, MELD score, and liver elasticity) and cardiac and portopulmonary hypertension factors.
b. Examine the relationship between portal hemodynamic severity (hepatic venous pressure gradient, Doppler flow factors in portal vein and portosystemic shunt) and cardiac function factors and pulmonary hypertension factors.
c. To examine changes in cardiac function and pulmonary hypertension factors after treatment of complications associated with portal hypertension.
d. Examine the relationship of prognosis to cardiac function and pulmonary hypertension factors.
e. Examine differences in endothelin, cytokines, and BMP9
by angiographic site and changes after treatment.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients scheduled for treatment of complications associated with portal hypertension (splenomegaly, portal hypertension, esophagogastric varices, refractory ascites) or patients suspected of having cirrhotic cardiomyopathy or portopulmonary hypertension due to respiratory distress, etc.
2) Age 20 years or older
3) Patients who have received sufficient explanation about the study after receiving sufficient explanation about their medical conditions and treatment methods, and who have obtained written consent of their own free will with sufficient understanding.
(1) Patients whom the principal investigator or sub-investigator judges to be inappropriate as subjects.
(2) Patients for whom outpatient follow-up at our hospital is difficult.
100
1st name | Kato |
Middle name | |
Last name | Naoya |
Chiba University Graduate School of Medicine
Deartment of Gastroenterology
260-8677
1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan
0432227171
takakon@chiba-u.jp
1st name | Kondo |
Middle name | |
Last name | Takayuki |
Chiba University Hospital
Department of Gastroenterology
260-8677
1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan
0432227171
takakon@chiba-u.jp
Chiba University
N/A
Other
Chiba Univesity Graduate School of Medicine, IRB
1-8-1, Inohana, Chuo-ku, Chiba, Japan
0432227171
inohana-rinri@chiba-u.jp
NO
2021 | Year | 01 | Month | 04 | Day |
Unpublished
Enrolling by invitation
2020 | Year | 10 | Month | 12 | Day |
2020 | Year | 12 | Month | 22 | Day |
2021 | Year | 01 | Month | 04 | Day |
2024 | Year | 03 | Month | 31 | Day |
N/A
2020 | Year | 12 | Month | 30 | Day |
2020 | Year | 12 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048938
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |